Participants 108 160 3
locally advanced squamous cell head and neck cancer.
Participants 363 549 5
One hundred and fifty-three patients (all of whom had stage III or IV unresectable disease with no distant metastases and who had received two cycles of taxol and cisplatin chemotherapy)
